Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy.
about
TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.NK cell heparanase controls tumor invasion and immune surveillance.Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies.Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis.NK Cell Exhaustion.CD155, an onco-immunologic molecule in human tumors.CIS is a potent checkpoint in NK cell-mediated tumor immunity.Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.CEACAM1 as a multi-purpose target for cancer immunotherapy.Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy.Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice.Recombinant Poliovirus for Cancer Immunotherapy.An ultrastructural investigation of tumors undergoing regression mediated by immunotherapy.CD96 expression determines the inflammatory potential of IL-9-producing Th9 cells.CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity.CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.Coming of Age: CD96 Emerges as Modulator of Immune Responses.Next generation immune-checkpoints for cancer therapy.Trial watch: Immunogenic cell death induction by anticancer chemotherapeuticsTargeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer CellsDeficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasisRANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancerUnchaining NK cell–mediated anticancer immunosurveillanceTNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
P2860
Q30399437-371ACD0B-2C93-4735-99DF-339E6E76364DQ38701256-B850DD17-4370-49B4-BC8A-24780F8A9603Q38840291-CF359B17-35BA-45D8-BC3D-E7157CD23A28Q38872473-0C387010-4812-486B-A9E4-8B136676525BQ38875021-3AE52C95-6566-49B8-AD45-2EF092C3C086Q39431541-C73C6EB8-32D7-4B02-9EBD-52C273769689Q39449823-AA593D96-46BE-48EC-99AF-1479EAD6059EQ39744193-7E28B9E5-B2A4-41A1-9A1E-889E4338D230Q40113311-DC44328E-6D9F-407D-8A73-C214714BD4B7Q41251368-F4EE76BD-0DD7-4935-9C09-188E32BE1262Q42660142-0F61307C-C917-47D3-B301-C53ED11EAC8AQ47221163-4ACDF3BE-EDC0-46FF-926E-101A91B86141Q47301132-4F80BFB4-7071-481C-AE18-848B9A76DFEAQ47595821-551CA37E-EDAC-44C9-A157-945BD9612AEEQ48508304-4A4F5542-8422-4D38-9C17-93A825F937F5Q49235374-78088FD5-FE7D-452E-9204-B09F95475F21Q52659614-FFCC6D4F-6AEA-460F-AEB5-66E30D1F6E31Q52714314-26EB316A-C2FA-4DF9-87EC-015C0EBB5D92Q54212829-67DDEB70-01B2-4035-9F5C-C85C1D0508F3Q55026846-8B33544E-6D49-4505-9541-AA5275D1BF8FQ55383705-4EA0D05D-CE02-498E-A604-FED9F4CD3C03Q56594845-451D98DF-F05D-4643-A1CB-2D244A26BFD0Q56889003-F10F858B-B596-4E39-B75B-7D7698ECDFD6Q56892731-876AE6C8-535C-4700-B820-7506D94DA5B4Q56892940-BD1DAA92-D29A-46E5-AB10-C45E0123FF68Q57082741-CCACBF50-FDBC-41BA-B6E0-60A08400E07FQ58621104-80823F37-8F67-4317-9B0B-0E895A53F326
P2860
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Suppression of Metastases Usin ...... rget for Cancer Immunotherapy.
@en
type
label
Suppression of Metastases Usin ...... rget for Cancer Immunotherapy.
@en
prefLabel
Suppression of Metastases Usin ...... rget for Cancer Immunotherapy.
@en
P2093
P50
P1433
P1476
Suppression of Metastases Usin ...... rget for Cancer Immunotherapy.
@en
P2093
Amelia Roman Aguilera
Deepak Mittal
Engin Gurlevik
Florian Kühnel
Kazuyoshi Takeda
Kimberley Stannard
Lucas Ferrari de Andrade
Michele W L Teng
Michelle C R Yong
P304
P356
10.1158/2159-8290.CD-15-0944
P577
2016-01-19T00:00:00Z